These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15084120)
1. Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors. Lepper ER; Ng SS; Gütschow M; Weiss M; Hauschildt S; Hecker TK; Luzzio FA; Eger K; Figg WD J Med Chem; 2004 Apr; 47(9):2219-27. PubMed ID: 15084120 [TBL] [Abstract][Full Text] [Related]
2. Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine. Luzzio FA; Mayorov AV; Ng SS; Kruger EA; Figg WD J Med Chem; 2003 Aug; 46(18):3793-9. PubMed ID: 12930142 [TBL] [Abstract][Full Text] [Related]
3. Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFalpha modulators. Avila CM; Romeiro NC; da Silva GM; Sant'Anna CM; Barreiro EJ; Fraga CA Bioorg Med Chem; 2006 Oct; 14(20):6874-85. PubMed ID: 16843662 [TBL] [Abstract][Full Text] [Related]
4. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues. Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment. Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405 [TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods. Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818 [TBL] [Abstract][Full Text] [Related]
10. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies. Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164 [TBL] [Abstract][Full Text] [Related]
11. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726 [TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies. Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759 [TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. Qin J; Liu H; Li J; Ren Y; Yao X; Liu M Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859 [TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735 [TBL] [Abstract][Full Text] [Related]
15. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. Murugesan V; Prabhakar YS; Katti SB J Mol Graph Model; 2009 Feb; 27(6):735-43. PubMed ID: 19117780 [TBL] [Abstract][Full Text] [Related]
18. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745 [TBL] [Abstract][Full Text] [Related]
19. Comparative molecular field analysis and comparative molecular similarity indices analysis of human thymidine kinase 1 substrates. Bandyopadhyaya AK; Johnsamuel J; Al-Madhoun AS; Eriksson S; Tjarks W Bioorg Med Chem; 2005 Mar; 13(5):1681-9. PubMed ID: 15698786 [TBL] [Abstract][Full Text] [Related]
20. Pharmacophore and docking-based combined in-silico study of KDR inhibitors. Pasha FA; Muddassar M; Neaz MM; Cho SJ J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]